Novartis Ag (NVS) Gains from Investment Securities (2009 - 2026)
Novartis Ag recorded quarterly Gains from Investment Securities of -$787.0 million in Q1 2026, up 19.78% quarter-over-quarter from -$981.0 million in Q4 2025, and down 45.74% year-over-year from -$1.5 billion in Q1 2025.
Novartis Ag's Gains from Investment Securities history runs 18 years deep, the most recent figure standing at -$787.0 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 45.74% year-over-year to -$787.0 million; the TTM figure through Mar 2026 stood at -$2.8 billion (down 26.42% YoY), while the FY2025 annual figure was -$981.0 million, changed N/A from the prior year.
- Gains from Investment Securities came in at -$787.0 million for Q1 2026 at Novartis Ag, up from -$981.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of -$260.0 million in Q3 2022 to a low of -$1.3 billion in Q4 2023.
- A 5-year average of -$611.9 million and a median of -$576.0 million in 2024 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities soared 62.17% in 2022 and tumbled 279.64% in 2023, its largest moves.
- Novartis Ag's Gains from Investment Securities stood at -$334.0 million in 2022, then sank by 279.64% to -$1.3 billion in 2023, then gained by 27.13% to -$924.0 million in 2024, then retreated by 6.17% to -$981.0 million in 2025, then increased by 19.78% to -$787.0 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$787.0 million, -$981.0 million, and -$366.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -787.00 Mn |
| Mar 31, 2026 | -787.00 Mn |
| Dec 31, 2025 | -981.00 Mn |
| Dec 31, 2025 | -981.00 Mn |
| Sep 30, 2025 | -366.00 Mn |
| Sep 30, 2025 | -366.00 Mn |
| Jun 30, 2025 | -675.00 Mn |
| Jun 30, 2025 | -675.00 Mn |
| Mar 31, 2025 | -540.00 Mn |
| Mar 31, 2025 | -540.00 Mn |
| Dec 31, 2024 | -924.00 Mn |
| Dec 31, 2024 | -924.00 Mn |
| Sep 30, 2024 | -285.00 Mn |
| Sep 30, 2024 | -285.00 Mn |
| Jun 30, 2024 | -473.00 Mn |
| Jun 30, 2024 | -473.00 Mn |
| Mar 31, 2024 | -576.00 Mn |
| Mar 31, 2024 | -576.00 Mn |
| Dec 31, 2023 | -1.27 Bn |
| Dec 31, 2023 | -1.27 Bn |
| Sep 30, 2023 | -426.00 Mn |
| Sep 30, 2023 | -426.00 Mn |
| Jun 30, 2023 | -973.00 Mn |
| Jun 30, 2023 | -973.00 Mn |
| Mar 31, 2023 | -295.00 Mn |
| Mar 31, 2023 | -295.00 Mn |
| Dec 31, 2022 | -334.00 Mn |
| Dec 31, 2022 | -334.00 Mn |
| Sep 30, 2022 | -260.00 Mn |
| Sep 30, 2022 | -260.00 Mn |
| Jun 30, 2022 | -606.00 Mn |
| Jun 30, 2022 | -606.00 Mn |
| Mar 31, 2022 | -633.00 Mn |
| Mar 31, 2022 | -633.00 Mn |
| Dec 31, 2021 | -883.00 Mn |
| Dec 31, 2021 | -883.00 Mn |
| Sep 30, 2021 | -315.00 Mn |
| Sep 30, 2021 | -315.00 Mn |
| Jun 30, 2021 | -409.00 Mn |
| Jun 30, 2021 | -409.00 Mn |
| Mar 31, 2021 | -735.00 Mn |
| Mar 31, 2021 | -735.00 Mn |
| Dec 31, 2020 | -618.00 Mn |
| Dec 31, 2020 | -618.00 Mn |
| Sep 30, 2020 | -316.00 Mn |
| Sep 30, 2020 | -316.00 Mn |
| Jun 30, 2020 | -303.00 Mn |
| Jun 30, 2020 | -303.00 Mn |
| Mar 31, 2020 | -596.00 Mn |
| Mar 31, 2020 | -596.00 Mn |
| Dec 31, 2019 | -681.00 Mn |
| Dec 31, 2019 | -681.00 Mn |
| Sep 30, 2019 | -235.00 Mn |
| Sep 30, 2019 | -235.00 Mn |
| Jun 30, 2019 | -560.00 Mn |
| Jun 30, 2019 | -560.00 Mn |
| Mar 31, 2019 | -400.00 Mn |
| Mar 31, 2019 | -400.00 Mn |
| Dec 31, 2018 | -397.00 Mn |
| Dec 31, 2018 | -397.00 Mn |
| Sep 30, 2018 | -219.00 Mn |
| Sep 30, 2018 | -219.00 Mn |
| Jun 30, 2018 | -501.00 Mn |
| Jun 30, 2018 | -501.00 Mn |
| Mar 31, 2018 | -389.00 Mn |
| Mar 31, 2018 | -389.00 Mn |
| Dec 31, 2017 | -486.00 Mn |
| Dec 31, 2017 | -486.00 Mn |
| Sep 30, 2017 | -221.00 Mn |
| Sep 30, 2017 | -221.00 Mn |
| Jun 30, 2017 | -467.00 Mn |
| Jun 30, 2017 | -467.00 Mn |
| Mar 31, 2017 | -437.00 Mn |
| Mar 31, 2017 | -437.00 Mn |
| Dec 31, 2016 | -791.00 Mn |
| Dec 31, 2016 | -791.00 Mn |
| Sep 30, 2016 | -339.00 Mn |
| Sep 30, 2016 | -339.00 Mn |
| Jun 30, 2016 | -462.00 Mn |
| Jun 30, 2016 | -462.00 Mn |
| Mar 31, 2016 | -519.00 Mn |
| Mar 31, 2016 | -519.00 Mn |
| Dec 31, 2015 | -528.00 Mn |
| Dec 31, 2015 | -528.00 Mn |
| Sep 30, 2015 | -824.00 Mn |
| Sep 30, 2015 | -824.00 Mn |
| Jun 30, 2015 | -524.00 |
| Jun 30, 2015 | -524.00 |
| Mar 31, 2015 | -578.00 |
| Mar 31, 2015 | -578.00 |
| Dec 31, 2014 | -559.00 |
| Dec 31, 2014 | -559.00 |
| Sep 30, 2014 | -394.00 |
| Sep 30, 2014 | -394.00 |
| Jun 30, 2014 | -544.00 |
| Jun 30, 2014 | -544.00 |
| Mar 31, 2014 | -682.00 |
| Mar 31, 2014 | -682.00 |
| Dec 31, 2013 | -509.00 |
| Dec 31, 2013 | -509.00 |
| Sep 30, 2013 | -419.00 |
| Sep 30, 2013 | -419.00 |
| Jun 30, 2013 | -644.00 |
| Jun 30, 2013 | -644.00 |
| Mar 31, 2013 | -497.00 |
| Mar 31, 2013 | -497.00 |
| Sep 30, 2012 | -374.00 |
| Sep 30, 2012 | -374.00 |
| Jun 30, 2012 | -972.00 |
| Jun 30, 2012 | -972.00 |
| Mar 31, 2012 | -347.00 |
| Mar 31, 2012 | -347.00 |
| Dec 31, 2011 | -670.00 |
| Dec 31, 2011 | -670.00 |
| Sep 30, 2011 | -321.00 |
| Sep 30, 2011 | -321.00 |
| Jun 30, 2011 | -674.00 |
| Jun 30, 2011 | -674.00 |
| Mar 31, 2011 | -770.00 |
| Mar 31, 2011 | -770.00 |
| Dec 31, 2010 | -530.00 |
| Dec 31, 2010 | -530.00 |
| Sep 30, 2010 | -638.00 |
| Sep 30, 2010 | -638.00 |
| Jun 30, 2010 | -979.00 |
| Jun 30, 2010 | -979.00 |
| Mar 31, 2010 | -469.00 |
| Mar 31, 2010 | -469.00 |
| Dec 31, 2009 | -406.00 |
| Dec 31, 2009 | -406.00 |
| Sep 30, 2009 | -289.00 |
| Sep 30, 2009 | -289.00 |
| Jun 30, 2009 | -591.00 |
| Jun 30, 2009 | -591.00 |
| Mar 31, 2009 | -337.00 |
| Mar 31, 2009 | -337.00 |